LLY

847.13

-6.39%↓

UNH

564.14

-1.53%↓

NVO

129.84

-4.18%↓

JNJ

155.3

-0.67%↓

MRK

124.28

-1.21%↓

LLY

847.13

-6.39%↓

UNH

564.14

-1.53%↓

NVO

129.84

-4.18%↓

JNJ

155.3

-0.67%↓

MRK

124.28

-1.21%↓

LLY

847.13

-6.39%↓

UNH

564.14

-1.53%↓

NVO

129.84

-4.18%↓

JNJ

155.3

-0.67%↓

MRK

124.28

-1.21%↓

LLY

847.13

-6.39%↓

UNH

564.14

-1.53%↓

NVO

129.84

-4.18%↓

JNJ

155.3

-0.67%↓

MRK

124.28

-1.21%↓

LLY

847.13

-6.39%↓

UNH

564.14

-1.53%↓

NVO

129.84

-4.18%↓

JNJ

155.3

-0.67%↓

MRK

124.28

-1.21%↓

Search

Boston Scientific Corp.

Fermé

Secteur Soins de santé

78.2 0.23

Résumé

Variation du prix de l'action

24h

Actuel

Min

77.64

Max

78.45

Chiffres clés

By Trading Economics

Revenu

-12M

492M

Ventes

135M

3.9B

P/E

Moyenne du Secteur

64.01

79.786

BPA

0.56

Marge bénéficiaire

12.746

Employés

48,000

EBITDA

-27M

981M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+8.65 upside

Dividendes

By Dow Jones

Prochains Résultats

24 juil. 2024

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3B

115B

Ouverture précédente

77.97

Clôture précédente

78.2

Sentiment de l'Actualité

By Acuity

27%

73%

51 / 369 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

Boston Scientific Corp. Graphique

Actualités Associées

18 juin 2024, 13:23 UTC

Acquisitions, Fusions, Rachats

Correction to Boston Scientific to Buy Silk Road Article

18 juin 2024, 11:41 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 juin 2024, 11:31 UTC

Acquisitions, Fusions, Rachats

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 avr. 2024, 11:01 UTC

Résultats

Boston Scientific Lifts 2024 Outlook After Strong 1Q

4 avr. 2024, 12:00 UTC

Acquisitions, Fusions, Rachats

Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information

18 juin 2024, 20:22 UTC

Acquisitions, Fusions, Rachats

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 juin 2024, 14:25 UTC

Acquisitions, Fusions, Rachats

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 juin 2024, 12:54 UTC

Acquisitions, Fusions, Rachats

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 juin 2024, 11:33 UTC

Acquisitions, Fusions, Rachats

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 juin 2024, 11:18 UTC

Acquisitions, Fusions, Rachats

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 juin 2024, 11:03 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 juin 2024, 11:02 UTC

Acquisitions, Fusions, Rachats

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 juin 2024, 11:01 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 juin 2024, 11:01 UTC

Acquisitions, Fusions, Rachats

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 juin 2024, 11:00 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 avr. 2024, 12:30 UTC

Actualités
Résultats

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24 avr. 2024, 10:36 UTC

Résultats

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24 avr. 2024, 10:35 UTC

Résultats

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific Sees 2024 Adj EPS $2.29-Adj EPS $2.34 >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific Sees 2024 EPS $1.43-EPS $1.48 >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific Sees 2Q Adj EPS 57c-Adj EPS 59c >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific Sees 2Q EPS 35c-EPS 37c >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific 1Q Adj EPS 56c >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific 1Q Sales $3.86B >BSX

24 avr. 2024, 10:31 UTC

Résultats

Boston Scientific 1Q EPS 33c >BSX

4 avr. 2024, 11:25 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Now Sees Mereger Closing in 2H of 2024 >BSX

4 avr. 2024, 11:24 UTC

Acquisitions, Fusions, Rachats

Boston Scientific, Axionics Expect to Promptly Respond to Second Request >BSX

4 avr. 2024, 11:24 UTC

Acquisitions, Fusions, Rachats

Boston Scientific, Axonics Receive Request for Additional Info From FTC Regarding Merger >BSX

31 janv. 2024, 14:19 UTC

Résultats

Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance -- IBD

31 janv. 2024, 12:59 UTC

Résultats

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts -- IBD

Comparaison

Variation de prix

Boston Scientific Corp. prévision

Objectif de Prix

By TipRanks

8.65% hausse

Prévisions sur 12 Mois

Moyen 84.9 USD  8.65%

Haut 95 USD

Bas 73 USD

Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

22 ratings

21

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

76.55 / 78.98Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

51 / 369Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.